ScholarIQanswers from OpenAlex & ORCID
Nathan Herrmann
ResearcherPublications, citations & collaboration network
Nathan Herrmann is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Nathan Herrmann have?
ScholarIQindexed works
Nathan Herrmann has 676 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Nathan Herrmann have?
ScholarIQcitation count
Nathan Herrmann has 33,716 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Nathan Herrmann?
ScholarIQh-index
Nathan Herrmann has an h-index of 83 in OpenAlex.
What is the i10-index of Nathan Herrmann?
ScholarIQi10-index
Nathan Herrmann has an i10-index of 370 in OpenAlex.
What is the ORCID of Nathan Herrmann?
ScholarIQorcid
The ORCID for Nathan Herrmann is on the source record.
What is the OpenAlex record for Nathan Herrmann?
ScholarIQopenalex
The OpenAlex for Nathan Herrmann is on the source record.
What are the most-cited papers on Nathan Herrmann?
ScholarIQmost cited works
Antipsychotic Drug Use and Mortality in Older Adults with Dementia
Sudeep S. Gill, Susan E. Bronskill, Sharon‐Lise T. Normand, George Anderson, Kathy Sykora, Kelvin Lam, Chaim M. Bell, Philip E. Lee, Hadas D. Fischer, Nathan Herrmann, Jerry H. Gurwitz, Paula A. Rochon
The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations
Zahinoor Ismail, Luis Agüera-Ortíz, Henry Brodaty, Alicja Cieślak, Jeffrey L. Cummings, Corinne E. Fischer, Serge Gauthier, Yonas E. Geda, Nathan Herrmann, Jamila Kanji, Krista L. Lanctôt, David S. Miller, Moyra E. Mortby, Chiadi U. Onyike, Paul B. Rosenberg, Eric E. Smith, Gwenn S. Smith, David L. Sultzer, Constantine G. Lyketsos
Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study
Sudeep S. Gill, Paula A. Rochon, Nathan Herrmann, Philip E. Lee, Kathy Sykora, Nadia Gunraj, Sharon‐Lise T. Normand, Jerry H. Gurwitz, Connie Marras, Walter P. Wodchis, Muhammad Mamdani
Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future
Yonas E. Geda, Lon S. Schneider, Laura N. Gitlin, David S. Miller, Gwenn S. Smith, J. Simon Bell, Jovier D. Evans, Michael K. Lee, Anton P. Porsteinsson, Krista L. Lanctôt, Paul B. Rosenberg, David L. Sultzer, Paul T. Francis, Henry Brodaty, Prasad P. Padala, Chiadikaobi Onyike, Luis Agüera Ortiz, Sonia Ancoli‐Israel, Donald L. Bliwise, Jennifer L. Martin, Michael V. Vitiello, Kristine Yaffe, Phyllis C. Zee, Nathan Herrmann, Robert A. Sweet, Clive Ballard, Ni A. Khin, Cara L. Alfaro, Patrick S. Murray, Susan K. Schultz, Constantine G. Lyketsos, Neuropsychiatric Syndromes Professional Interest Area of ISTAART
“Good Outcome” Isn’t Good Enough
Arunima Kapoor, Krista L. Lanctôt, Mark Bayley, Alex Kiss, Nathan Herrmann, Brian J. Murray, Richard H. Swartz